桂枝茯苓丸聯(lián)合米非司酮對(duì)子宮肌瘤的治療效果探討

打開文本圖片集

【摘要】目的：探討桂枝茯苓丸聯(lián)合米非司酮對(duì)子宮肌瘤的治療效果。方法：從本院于2020年1月—2023年1月間收治的子宮肌瘤患者中，隨機(jī)抽選80例患者作為研究對(duì)象，應(yīng)用隨機(jī)數(shù)字表法，分為實(shí)驗(yàn)組和對(duì)照組，對(duì)照組給予米非司酮治療，實(shí)驗(yàn)組給予米非司酮聯(lián)合桂枝茯苓丸治療，兩組各40例，比較兩組治療效果。結(jié)果：在血清激素水平方面，治療后，實(shí)驗(yàn)組的E2、FSH、LH、P明顯低于對(duì)照組（P

【關(guān)鍵詞】桂枝茯苓丸；米非司酮；子宮肌瘤

Therapeutic Effect of Guizhi Fuling Pills Combined with Mifepristone on Hysteromyoma

SU Changhua， LIU Runping

Yang County Hospital of Traditional Chinese Medicine， Hanzhong， Shaanxi 723300， China

【Abstract】Objective： To investigate the therapeutic effect of Guizhi Fuling pills combined with mifepristone on hysteromyoma. Methods： From January 2020 to January 2023， 80 patients with hysteromyoma were randomly selected as research objects and divided into experimental group and control group by random number table method. The control group was treated with mifepristone， and the experimental group was treated with mifepristone combined with Guizhi Fuling pills， with 40 cases in each group. The treatment effects of the two groups were compared. Results： In terms of serum hormone levels， after treatment， E2， FSH， LH， P in the experimental group were significantly lower than those in the control group （P

【Key Words】Guizhi Fuling Pills； Mifepristone； Hysteromyoma

在婦科腫瘤中，子宮肌瘤屬于良性腫瘤的一種[1]。（剩余4201字）